Non-small cell lung cancer (NSCLC) is a heterogeneous disorder consisting of distinct molecular subtypes each characterised by specific genetic and epigenetic profiles. Here, we aimed to identify novel NSCLC subtypes based on genome-wide methylation data, assess their relationship with smoking behaviour, age, COPD, emphysema and tumour histopathology, and identify the molecular pathways underlying each subtype.status: publishe
Background: Examining immunity-related DNA methylation alterations in blood could help elucidate the...
Abstract:Molecular genetic studies of lung cancer have revealed that clinically evident lung cancers...
Introduction:Lung cancer and chronic obstructive pulmonary disease (COPD) share environmental risk f...
Non-small cell lung cancer (NSCLC) is a heterogeneous disorder consisting of distinct molecular subt...
Introduction: Non-small-cell lung cancer exhibits a range of transcriptional and epigenetic patterns...
BackgroundAlthough the associations between genetic variations and lung cancer risk have been explor...
Lung cancer and chronic obstructive pulmonary disease (COPD) are two smoking-related respiratory dis...
Lung cancer accounts for 1.6 million cancers annually and 1.3 million deaths per year make the disea...
Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung disease associated ...
Background: Epigenetics changes have been shown to be affected by cigarette smoking. Cigarette smoke...
Background: Around the world, lung cancer is the leading cause of cancer-related death and a major p...
Background: Non-small cell lung carcinoma (NSCLC) is a complex malignancy that owing to its heteroge...
Purpose: Lung cancer is the worldwide leading cause of death from cancer. DNA methylation in gene pr...
Objectives: Smoking is a common risk factor for chronic obstructive pulmonary disease (COPD) and lun...
Rationale: Chronic obstructive pulmonary disease (COPD) is associated with local (lung) and systemic...
Background: Examining immunity-related DNA methylation alterations in blood could help elucidate the...
Abstract:Molecular genetic studies of lung cancer have revealed that clinically evident lung cancers...
Introduction:Lung cancer and chronic obstructive pulmonary disease (COPD) share environmental risk f...
Non-small cell lung cancer (NSCLC) is a heterogeneous disorder consisting of distinct molecular subt...
Introduction: Non-small-cell lung cancer exhibits a range of transcriptional and epigenetic patterns...
BackgroundAlthough the associations between genetic variations and lung cancer risk have been explor...
Lung cancer and chronic obstructive pulmonary disease (COPD) are two smoking-related respiratory dis...
Lung cancer accounts for 1.6 million cancers annually and 1.3 million deaths per year make the disea...
Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung disease associated ...
Background: Epigenetics changes have been shown to be affected by cigarette smoking. Cigarette smoke...
Background: Around the world, lung cancer is the leading cause of cancer-related death and a major p...
Background: Non-small cell lung carcinoma (NSCLC) is a complex malignancy that owing to its heteroge...
Purpose: Lung cancer is the worldwide leading cause of death from cancer. DNA methylation in gene pr...
Objectives: Smoking is a common risk factor for chronic obstructive pulmonary disease (COPD) and lun...
Rationale: Chronic obstructive pulmonary disease (COPD) is associated with local (lung) and systemic...
Background: Examining immunity-related DNA methylation alterations in blood could help elucidate the...
Abstract:Molecular genetic studies of lung cancer have revealed that clinically evident lung cancers...
Introduction:Lung cancer and chronic obstructive pulmonary disease (COPD) share environmental risk f...